House of Transplant & Cancer

EIN: 832318168 501(c)(3) Health Care

Torrance, CA

Total Revenue
$1,025,624
Total Expenses
$1,281,675
Total Assets
$295,517
Net Assets
$294,998
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2018
Legal Domicile
CA
Phone
3104000645
Tax Period
2023-01-01 to 2023-12-31

House of Transplant & Cancer, founded in 2018, is a community nonprofit in the Health Care sector that reported $1.0M in total revenue in fiscal year 2023. Revenue decreased 8% compared to the prior year. Expenses of $1.3M exceeded revenue, resulting in a 25% operating deficit.

Mission

The specific purpose of this corporation is to provide health care, scientific, and public health services to people with medical illness.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $76
Program Service Revenue $1,043,774
Investment Income $-18,226
Other Revenue $0
TOTAL REVENUE $1,025,624

Expense Breakdown

Grants Paid $205
Salaries & Benefits $880,812
Fundraising Expenses $0
Program Expenses $1,153,529
Other Expenses $400,658
TOTAL EXPENSES $1,281,675

Year-over-Year Comparison

2023 2022 Change
Revenue $1,025,624 $1,118,857 -0.1%
Expenses $1,281,675 $1,166,785 +0.1%
Net Income $-256,051 $-47,928 +4.3%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
N/A
Employees
26
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
0
$0
Total Directors
2
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Alagappan Annamalai CEO 25.00
Director
$0 $0 $0
Elise Diner CEO 40.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $1,025,624 $1,281,675 $295,517 $-256,051
2022 $1,118,857 $1,166,785 $401,683 $-47,928
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare House of Transplant & Cancer with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.